Home Procurement NewsFTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition

FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition

September 1, 2023•

The FTC had filed a lawsuit in May seeking to block the acquisition, arguing that the deal would “stifle competition” in the pharmaceutical industry.

Was this article helpful?

YesNo

Last modified: September 1, 2023

Previous: The Landscape of Gambling in Africa: Revenue Set to Hit $1.62 Billion with 27.5 Million Users by 2023

Next: Gabon’s transitional leader threatens business owners over corruption

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

The articles and content featured on this platform are sourced from various contributors and do not necessarily reflect the views or positions of Accountability Lab Nigeria. We do not author or edit the published materials. If you have concerns about any content or would like to request its removal, please contact us at @Accountability Lab Nigeria.

Recent Posts

Recent Comments

No comments to show.

Are you ready to join the Community?

Join the Conversation!

Community of Practice Portal aims to bring together key stakeholders in the procurement landscape in Nigeria to leverage on each others skillset in relation to understanding Procurement data in a bid to use these data to create stories and to generate action from the government.

Community of practice platform is an initiative under Anti-Corruption Innovation Project, a UNDP funded Project in collaboration with Accountability lab Nigeria, and Open Contracting Partnerships

Accountability Lab Nigeria

Copyright © 2021 - Accountability Lab Nigeria

↑

Close